A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

NCT06311682 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Tralokinumab + TCS
DRUG: Placebo + TCS

Sponsor

LEO Pharma